From Breakthrough to Bedside: Aligning Regulatory Strategy, Clinical Evidence and Commercialization in Diagnostics

The discussion will cover critical intersections between regulatory strategy, clinical validation and commercialization, including FDA pathways, clinical study design and how to position programs for investment and scale.

For questions, contact Frances Luu.